BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37097596)

  • 1. Central nervous system reactivation of herpesviridae family in patients with COVID-19.
    Haddad M; Sheybani F; Olfati N; Nahayati MA; Boostani R; Layegh P; Rashid-Nejad A
    J Neurovirol; 2023 Apr; 29(2):211-217. PubMed ID: 37097596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central nervous system complications in SARS-CoV-2-infected patients.
    Li Z; Lin D; Xu X; Liu X; Zhang J; Huang K; Wang F; Liu J; Zhang Z; Tao E
    J Neurol; 2023 Oct; 270(10):4617-4631. PubMed ID: 37573554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Encephalitis in Patients with COVID-19: A Systematic Evidence-Based Analysis.
    Islam MA; Cavestro C; Alam SS; Kundu S; Kamal MA; Reza F
    Cells; 2022 Aug; 11(16):. PubMed ID: 36010650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Mechanisms of SARS-CoV-2/COVID-19 Pathogenicity on the Central Nervous System: Bridging Experimental Probes to Clinical Evidence and Therapeutic Interventions.
    Groppa SA; Ciolac D; Duarte C; Garcia C; Gasnaș D; Leahu P; Efremova D; Gasnaș A; Bălănuță T; Mîrzac D; Movila A
    Adv Exp Med Biol; 2022; 1376():1-27. PubMed ID: 34735712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Encephalitic syndrome and anosmia in COVID-19: Do these clinical presentations really reflect SARS-CoV-2 neurotropism? A theory based on the review of 25 COVID-19 cases.
    Pouga L
    J Med Virol; 2021 Jan; 93(1):550-558. PubMed ID: 32672843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central neuroinflammation in Covid-19: a systematic review of 182 cases with encephalitis, acute disseminated encephalomyelitis, and necrotizing encephalopathies.
    Zamani R; Pouremamali R; Rezaei N
    Rev Neurosci; 2022 Jun; 33(4):397-412. PubMed ID: 34536341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological Sequelae of COVID-19.
    Ahmad SJ; Feigen CM; Vazquez JP; Kobets AJ; Altschul DJ
    J Integr Neurosci; 2022 Apr; 21(3):77. PubMed ID: 35633158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid analysis in patients with COVID-19-associated central nervous system manifestations: a systematic review.
    Domingues RB; Leite FBVM; Senne C
    Arq Neuropsiquiatr; 2022 Mar; 80(3):296-305. PubMed ID: 35239818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpesvirus reactivation during severe COVID-19 and high rate of immune defect.
    Saade A; Moratelli G; Azoulay E; Darmon M
    Infect Dis Now; 2021 Nov; 51(8):676-679. PubMed ID: 34332165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.
    Jha NK; Ojha S; Jha SK; Dureja H; Singh SK; Shukla SD; Chellappan DK; Gupta G; Bhardwaj S; Kumar N; Jeyaraman M; Jain R; Muthu S; Kar R; Kumar D; Goswami VK; Ruokolainen J; Kesari KK; Singh SK; Dua K
    J Mol Neurosci; 2021 Nov; 71(11):2192-2209. PubMed ID: 33464535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 infection and vaccines: potential triggers of Herpesviridae reactivation.
    Navarro-Bielsa A; Gracia-Cazaña T; Aldea-Manrique B; Abadías-Granado I; Ballano A; Bernad I; Gilaberte Y
    An Bras Dermatol; 2023; 98(3):347-354. PubMed ID: 36803914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpesviridae systemic reactivation in patients with COVID-19-associated ARDS.
    Reizine F; Liard C; Pronier C; Thibault V; Maamar A; Gacouin A; Tadié JM
    J Hosp Infect; 2022 Jan; 119():189-191. PubMed ID: 34800612
    [No Abstract]   [Full Text] [Related]  

  • 13. Lethal encephalitis in a pediatric patient with SARS-CoV-2.
    Yimenicioğlu S; Zararcı K; Aynacı AM; Yılmaz AT
    Turk J Pediatr; 2022; 64(3):571-575. PubMed ID: 35899571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroimaging manifestations in children with SARS-CoV-2 infection: a multinational, multicentre collaborative study.
    Lindan CE; Mankad K; Ram D; Kociolek LK; Silvera VM; Boddaert N; Stivaros SM; Palasis S;
    Lancet Child Adolesc Health; 2021 Mar; 5(3):167-177. PubMed ID: 33338439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myoclonus status revealing COVID 19 infection.
    Ben Mohamed D; Zouari R; Ketata J; Nabli F; Blel S; Ben Sassi S
    Seizure; 2023 Jan; 104():12-14. PubMed ID: 36446232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotropism and Neuropsychiatric Symptomsi in Patients with COVID-19.
    Moretti P; Brufani F; Pierotti V; Pomili G; Di Buò A; Giulietti C; Masini F; Tanku V; Bachetti MC; Menculini G; Tortorella A
    Psychiatr Danub; 2021 Dec; 33(Suppl 11):10-13. PubMed ID: 34862882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroimaging Patterns in Patients with COVID-19-Associated Neurological Complications: A Review.
    Garg RK; Paliwal VK; Malhotra HS; Sharma PK
    Neurol India; 2021; 69(2):260-271. PubMed ID: 33904434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurological associations of COVID-19.
    Ellul MA; Benjamin L; Singh B; Lant S; Michael BD; Easton A; Kneen R; Defres S; Sejvar J; Solomon T
    Lancet Neurol; 2020 Sep; 19(9):767-783. PubMed ID: 32622375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herpesvirus infections and post-COVID-19 manifestations: a pilot observational study.
    Zubchenko S; Kril I; Nadizhko O; Matsyura O; Chopyak V
    Rheumatol Int; 2022 Sep; 42(9):1523-1530. PubMed ID: 35650445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpesvirus and neurological manifestations in patients with severe coronavirus disease.
    Carneiro VCS; Alves-Leon SV; Sarmento DJS; Coelho WLDCNP; Moreira ODC; Salvio AL; Ramos CHF; Ramos Filho CHF; Marques CAB; da Costa Gonçalves JP; Leon LAA; de Paula VS
    Virol J; 2022 Jun; 19(1):101. PubMed ID: 35676707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.